6,626
Views
34
CrossRef citations to date
0
Altmetric
Perspectives

Medication-assisted treatment for youth with opioid use disorder: Current dilemmas and remaining questions

, ORCID Icon, &
Pages 143-146 | Received 07 Apr 2017, Accepted 28 Oct 2017, Published online: 30 Nov 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Aaron Hogue, Molly Bobek, Nicole Porter, Alexandra MacLean, Kevin Wenzel, Marc Fishman, J. Douglas Coatsworth & David. A. Langer. (2023) Launching Relationship-Oriented Behavioral Services for Youth Opioid Use Disorder: Innovations in Medication Decision-Making and Adherence Planning. Child & Family Behavior Therapy 45:3, pages 199-225.
Read now
Joshua M. Nadeau & Sim Yin Tan. (2023) Considerations for intensive treatment programs among youth with medical and behavioral health concerns. Children's Health Care 52:1, pages 1-6.
Read now
Ariel Ludwig, Laura B. Monico, Elizabeth Lertch, Robert P. Schwartz, Marc Fishman & Shannon Gwin Mitchell. (2021) Until there’s nothing left: Caregiver resource provision to youth with opioid use disorders. Substance Abuse 42:4, pages 990-997.
Read now
Grant A. Victor, Katie Bailey & Brad Ray. (2021) Buprenorphine Treatment Intake and Critical Encounters following a Nonfatal Opioid Overdose. Substance Use & Misuse 56:7, pages 988-996.
Read now

Articles from other publishers (30)

Laura B. Monico, Jesse B. Fletcher, Tyler Ross, Robert P. Schwartz, Marc J. Fishman, Jan Gryczynski & Shannon Gwin Mitchell. (2024) Patient and provider medication preferences affect treatment outcomes among adolescents and young adults with opioid use disorder. Journal of Substance Use and Addiction Treatment 162, pages 209334.
Crossref
Brian R. Russ & Jessica D. Gorham. (2023) Treating Adolescents With Opioid Use Disorder: A Medication-Assisted Treatment Approach. The Family Journal 32:2, pages 215-221.
Crossref
Shannon Gwin Mitchell, Jesse B. Fletcher, Laura B. Monico, Jan Gryczynski, Marc J. Fishman, Kevin E. O'Grady & Robert P. Schwartz. (2023) Comparing outcomes of extended-release naltrexone in adolescents and young adults with opioid use disorder. Journal of Substance Use and Addiction Treatment, pages 209162.
Crossref
Karen Alexander, Megan K. Reed & Robert C. Sterling. (2023) The interaction of race and age in methadone treatment retention outcomes: A single-center analysis. Journal of Substance Use and Addiction Treatment 148, pages 209020.
Crossref
Shuang Wang, Kimford J. Meador, Jayne Pawasauskas, Adam K. Lewkowitz, Kristina E. Ward, Todd N. Brothers, Abraham Hartzema, Brian J. Quilliam & Xuerong Wen. (2023) Comparative Safety Analysis of Opioid Agonist Treatment in Pregnant Women with Opioid Use Disorder: A Population-Based Study. Drug Safety 46:3, pages 257-271.
Crossref
Danica K. Knight, Steven Belenko, Michael L. Dennis, Gail A. Wasserman, George W. Joe, Gregory A. Aarons, John P. Bartkowski, Jennifer E. Becan, Katherine S. Elkington, Aaron Hogue, Larkin S. McReynolds, Angela A. Robertson, Yang Yang & Tisha R. A. Wiley. (2022) The comparative effectiveness of Core versus Core+Enhanced implementation strategies in a randomized controlled trial to improve substance use treatment receipt among justice-involved youth. BMC Health Services Research 22:1.
Crossref
Andreas Pilarinos, Danya Fast, Ekaterina Nosova, Yandi Kwa, Ronald Joe, Jane A. Buxton & Kora DeBeck. (2022) Initiation of opioid agonist treatment and subsequent substance use and other patterns among adolescents and young adults in Vancouver, Canada. Drug and Alcohol Dependence 235, pages 109441.
Crossref
Jean Nicolas Westenberg, Andy M. Y. Tai, Julie Elsner, Mostafa M. Kamel, James S. H. Wong, Pouya Azar, Dzung X. Vo, Eva Moore, Nickie Mathew, Vijay Seethapathy, Fiona Choi, Marc Vogel & Reinhard M. Krausz. (2021) Treatment approaches and outcome trajectories for youth with high‐risk opioid use: A narrative review. Early Intervention in Psychiatry 16:3, pages 207-220.
Crossref
Andreas Pilarinos, Daniel J. Bromberg & Mohammad Karamouzian. (2022) A ccess to Medications for Opioid Use Disorder and Associated Factors Among Adolescents and Young Adults . JAMA Pediatrics 176:3, pages 304.
Crossref
Sara J. Becker, Kelli Scott, Sarah A. Helseth, Kristin J. Danko, Ethan M. Balk, Ian J. Saldanha, Gaelen P. Adam & Dale W. Steele. (2022) Effectiveness of medication for opioid use disorders in transition-age youth: A systematic review. Journal of Substance Abuse Treatment 132, pages 108494.
Crossref
Emanuel Krebs, Jeong E. Min, Haoxuan Zhou, Carolyn Davison, Gina McGowan & Bohdan Nosyk. (2021) The cascade of care for opioid use disorder among youth in British Columbia, 2018. Journal of Substance Abuse Treatment 130, pages 108404.
Crossref
Marc Fishman, Kevin Wenzel, Jennifer Scodes, Martina Pavlicova, Aimee N. C. Campbell, John Rotrosen & Edward Nunes. (2021) Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial. The American Journal on Addictions 30:5, pages 433-444.
Crossref
G. Mohler, S. Mishra, B. Ray, L. Magee, P. Huynh, M. Canada, D. O’Donnell & S. Flaxman. (2021) A modified two-process Knox test for investigating the relationship between law enforcement opioid seizures and overdoses. Proceedings of the Royal Society A: Mathematical, Physical and Engineering Sciences 477:2250.
Crossref
Kevin Wenzel, Victoria Selby, Jared Wildberger, Luciana Lavorato, Julia Thomas & Marc Fishman. (2021) Choice of extended release medication for OUD in young adults (buprenorphine or naltrexone): A pilot enhancement of the Youth Opioid Recovery Support (YORS) intervention. Journal of Substance Abuse Treatment 125, pages 108306.
Crossref
Ilya Rozenberg & Karan Kverno. (2021) Medication Treatments for Youth and Young Adults With Opioid Use Disorder. Journal of Psychosocial Nursing and Mental Health Services 59:5, pages 9-13.
Crossref
Aaron Hogue, Molly Bobek, Sharon Levy, Craig E. Henderson, Marc Fishman, Sara J. Becker, Sarah Dauber, Nicole Porter & Kevin Wenzel. (2021) Conceptual framework for telehealth strategies to increase family involvement in treatment and recovery for youth opioid use disorder. Journal of Marital and Family Therapy 47:2, pages 501-514.
Crossref
Marc Fishman, Kevin Wenzel, Hoa Vo, Jared Wildberger & Rachael Burgower. (2020) A pilot randomized controlled trial of assertive treatment including family involvement and home delivery of medication for young adults with opioid use disorder. Addiction 116:3, pages 548-557.
Crossref
Marc Fishman, Kevin Wenzel, Jennifer Scodes, Martina Pavlicova, Joshua D. Lee, John Rotrosen & Edward Nunes. (2020) Young Adults Have Worse Outcomes Than Older Adults: Secondary Analysis of a Medication Trial for Opioid Use Disorder. Journal of Adolescent Health 67:6, pages 778-785.
Crossref
Grant I. G. Christie, Ali Cheetham & Dan I. Lubman. (2020) Interventions for Alcohol and Drug Use Disorders in Young People: 10 Key Evidence-Based Approaches to Inform Service Delivery. Current Addiction Reports 7:4, pages 464-474.
Crossref
Pouya Azar, James S.H. Wong, Sara Jassemi, Eva Moore, Dzung X. Vo, Mohammadali Nikoo & Samantha Young. (2020) A Case Report: Rapid Micro‐Induction of Buprenorphine/Naloxone to Administer Buprenorphine Extended‐Release in an Adolescent With Severe Opioid Use Disorder. The American Journal on Addictions 29:6, pages 531-535.
Crossref
Ranmalie Jayasinha, Stephanie Nairn & Patricia Conrod. (2020) A Dangerous “Cocktail”: The COVID-19 Pandemic and the Youth Opioid Crisis in North America: A Response to Vigo et al. (2020). The Canadian Journal of Psychiatry 65:10, pages 692-694.
Crossref
Alison Knopf. (2020) Opioid use disorder and youth: Agonists recommended. The Brown University Child & Adolescent Psychopharmacology Update 22:4, pages 1-4.
Crossref
Adam Viera, Daniel J Bromberg, Shannon Whittaker, Bryan M Refsland, Milena Stanojlović, Kate Nyhan & Frederick L Altice. (2020) Adherence to and Retention in Medications for Opioid Use Disorder Among Adolescents and Young Adults. Epidemiologic Reviews 42:1, pages 41-56.
Crossref
Charles J. Neighbors, Sugy Choi, Shannon Healy, Rajeev Yerneni, Tong Sun & Liudmila Shapoval. (2019) Age related medication for addiction treatment (MAT) use for opioid use disorder among Medicaid-insured patients in New York. Substance Abuse Treatment, Prevention, and Policy 14:1.
Crossref
Jason A. Ford. (2019) Prescription Opioid Misuse Among Adolescents. Pediatric Clinics of North America 66:6, pages 1099-1108.
Crossref
Lovdeep Kaur, Eman Tadros & Rikki Patton. (2019) The Role of Family in Youth Opioid Misuse: A Literature Review. The Family Journal 27:4, pages 429-442.
Crossref
Rachael M. LyonsAmy M. YuleDavida SchiffSarah M. BagleyTimothy E. Wilens. (2019) Risk Factors for Drug Overdose in Young People: A Systematic Review of the Literature. Journal of Child and Adolescent Psychopharmacology 29:7, pages 487-497.
Crossref
Elizabeth E. Krans, Joo Yeon Kim, Alton Everette James, David Kelley & Marian P. Jarlenski. (2019) Medication-Assisted Treatment Use Among Pregnant Women With Opioid Use Disorder. Obstetrics & Gynecology 133:5, pages 943-951.
Crossref
Justine W. WelshYujia ShentuDana B. Sarvey. (2019) Substance Use Among College Students. FOCUS 17:2, pages 117-127.
Crossref
Amy M. Yule, Rachael M. Lyons & Timothy E. Wilens. (2018) Opioid Use Disorders in Adolescents—Updates in Assessment and Management. Current Pediatrics Reports 6:2, pages 99-106.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.